Spero Therapeutics Inc

NASDAQ:SPRO   3:59:50 PM EDT
1.39
-0.06 (-3.82%)
Earnings Announcements

Spero Therapeutics Inc Reports Quarterly Loss Per Share $0.90

Published: 03/31/2022 21:24 GMT
Spero Therapeutics Inc (SPRO) - Spero Therapeutics Inc Qtrly Loss per Share $0.90.
Further Company Coverage: Sproo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $1.95 Million
Adjusted EPS is expected to be -$0.83

Next Quarter Revenue Guidance is expected to be $2.14 Million
Next Quarter EPS Guidance is expected to be -$0.59

More details on our Analysts Page.